China ECG Equipments Market Report 2022 to 2030

China ECG Equipments Market Analysis

$ 3999

The China ECG Equipment Market is expected to witness growth from $716 Mn in 2022 to $1406 Mn in 2030 with a CAGR of 8.80% for the forecasted year 2022-2030. In China, heart illness is one of the main causes of death and is becoming more common. Due to this, the need for ECG equipment to diagnose and track heart disease is on the rise. The market is segmented by product type and by the end user. Some key players in this market include Mindray, Edan Instruments, Johnson & Johnson, Philipps Healthcare, Medtronic, Biolight and Dexcom.

ID: IN10CNMD008 CATEGORY: Medical Devices GEOGRAPHY: China AUTHOR: Jigyasu Bhandari

Buy Now

China ECG Equipment Healthcare Market Executive Analysis

The China ECG Equipment Market size is at around $716 Mn in 2022 and is projected to reach $1406 Mn in 2030, exhibiting a CAGR of 8.80% during the forecast period. Over $1.12 trillion was spent on healthcare in China overall in 2021. For the first time, in 2017, more than one billion individuals had access to basic health insurance. More than 96% of people had access to health insurance in 2019.

In China, the age-standardized incidence rate of a heart attack (acute myocardial infarction, or AMI) rose from 5.1 per 10,000 person-years in 2015 to 5.6 per 10,000 people in 2021. In China, ECG equipment is a crucial instrument for the diagnosis and treatment of cardiac attacks. An ECG is typically one of the first tests done to help identify the condition when a person exhibits heart attack symptoms like chest pain, shortness of breath, or sweating. In hospitals and clinics throughout China, ECG equipment is readily accessible, and the majority of medical personnel are trained to use it. The electrical activity of the heart is captured by ECG devices, which can be used to spot anomalies that are indicative of a heart attack. ECG equipment can be used to evaluate the efficacy of treatment and spot any complications while monitoring the heart function of patients with existing heart disease. ECG equipment can be used to remotely monitor heart disease patients, enabling medical personnel to check on their heart health and alter treatment as necessary. ECG equipment can be used to track any abnormalities or possible risks in the heart health of athletes or individuals undertaking physical training.

China ECG Equipment Market Analysis

Market Dynamics

Market Growth Drivers

In China, heart illness is one of the main causes of death and is becoming more common. Due to this, the need for ECG equipment to diagnose and track heart disease is on the rise. The growing middle class and higher income levels in China are driving up healthcare expenditure. For companies that make ECG equipment, this expands their group of potential clients. Investments in healthcare technology and infrastructure are just a couple of the measures the Chinese government has put in place to raise the standard of healthcare provided in the nation. ECG equipment producers now have the chance to join the market and grow their businesses as a result of this.

Market Restraints

In China, as a result of the absence of standardisation in the ECG equipment market, consumers may become perplexed and manufacturers may find it challenging to differentiate their goods. In China, there is a high demand for affordable choices due to the market's price sensitivity. Making a profit while competing on price can be difficult for producers as a result.

Competitive Landscape

Key Players

Biolight (CN)
Mindray (CN)
Edan Instruments (CN)
Johnson & Johnson
Medtronic
Philipps Healthcare
Dexcom

Healthcare Policies and Regulatory Landscape

In China, the National Medical Products Administration (NMPA) is the main body in charge of regulating ECG equipment. ECG devices' safety, effectiveness, and quality are governed by the NMPA. Before it can be distributed in China, ECG equipment must register with the NMPA. To make sure the device complies with regulatory standards, testing and evaluation are part of the registration procedure. ECG equipment producers are required by Chinese Good Manufacturing Practice (GMP) laws to follow quality control guidelines. These laws are designed to guarantee the consistent and secure production of medical equipment. The National Healthcare Security Administration (NHSA) oversees reimbursement guidelines for ECG devices in China. Which ECG equipment is qualified for reimbursement and how much reimbursement will be given are decisions made by the NHSA.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

ECG Equipment Market Segmentation

By Product Type (Revenue, USD Billion):

Holter Monitors
Resting ECG Machines
Stress ECG Machines
Event Monitoring Systems
ECG Management Systems
Cardiopulmonary Stress Testing Systems

By End User (Revenue, USD Billion):

Hospitals and Clinics
Diagnostic Centres
Ambulatory Services
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

Yes, I have read the privacy policy

The market is segmented by type and by the end user.

The China ECG Equipment Market is studied from 2022-2030.

Edan Instruments, Johnson & Johnson, Philipps Healthcare, Medtronic, Biolight and Dexcom are the major companies operating in China's ECG Equipment market.